{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:55:42Z","timestamp":1793444142025,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["R01DK112782"],"award-info":[{"award-number":["R01DK112782"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00240-018-1101-7","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T05:38:16Z","timestamp":1543901896000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Cystinuria: genetic aspects, mouse models, and a new approach to therapy"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-673X","authenticated-orcid":false,"given":"Amrik","family":"Sahota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Tischfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"1101_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00240-015-0841-x","volume":"44","author":"KH Andreassen","year":"2016","unstructured":"Andreassen KH, Pedersen KV, Osther SS, Jung HU, Lildal SK, Osther PJ (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44:65\u201376. \n                    https:\/\/doi.org\/10.1007\/s00240-015-0841-x","journal-title":"Urolithiasis"},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","volume":"28","author":"VO Edvardsson","year":"2013","unstructured":"Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28:1923\u20131942. \n                    https:\/\/doi.org\/10.1007\/s00467-012-2329-z","journal-title":"Pediatr Nephrol"},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-7-19","volume":"7","author":"T Eggermann","year":"2012","unstructured":"Eggermann T, Venghaus A, Zerres K (2012) Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis 7:19. \n                    https:\/\/doi.org\/10.1186\/1750-1172-7-19","journal-title":"Orphanet J Rare Dis"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5414\/CN108514","volume":"83","author":"DJ Pereira","year":"2015","unstructured":"Pereira DJ, Schoolwerth AC, Pais VM (2015) Cystinuria: current concepts and future directions. Clin Nephrol 83:138\u2013146","journal-title":"Clin Nephrol"},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.urology.2013.10.013","volume":"83","author":"P Saravakos","year":"2014","unstructured":"Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83:693\u2013699. \n                    https:\/\/doi.org\/10.1016\/j.urology.2013.10.013","journal-title":"Urology"},{"key":"1101_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MNH.0b013e3283621c5d","volume":"22","author":"N Sumorok","year":"2013","unstructured":"Sumorok N, Goldfarb DS (2013) Update on cystinuria. Curr Opin Nephrol Hypertens 22:427\u2013431. \n                    https:\/\/doi.org\/10.1097\/MNH.0b013e3283621c5d","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1101_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrurol.2014.51","volume":"11","author":"K Thomas","year":"2014","unstructured":"Thomas K, Wong K, Withington J, Bultitude M, Doherty A (2014) Cystinuria-a urologist\u2019s perspective. Nat Rev Urol 11:270\u2013277. \n                    https:\/\/doi.org\/10.1038\/nrurol.2014.51","journal-title":"Nat Rev Urol"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.eeus.2006.06.001","volume":"4","author":"CS Biyani","year":"2006","unstructured":"Biyani CS, Cartledge JJ (2006) Cystinuria\u2014diagnosis and management. EAU-EBU Update Ser 4:175\u2013183","journal-title":"EAU-EBU Update Ser"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0094-0143(05)70262-7","volume":"27","author":"BF Schwartz","year":"2000","unstructured":"Schwartz BF, Stoller ML (2000) The vesical calculus. Urol Clin N A 27:333\u2013346","journal-title":"Urol Clin N A"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000087810","volume":"75","author":"C Schwentner","year":"2005","unstructured":"Schwentner C, Oswald J, Lunacek A, Bartsch G, Radmayr C (2005) Giant cystine stone in an infant bladder with no evidence of cystinuria-valence of possible pathomechanisms. Urol Int 75:285\u2013287. \n                    https:\/\/doi.org\/10.1159\/000087810","journal-title":"Urol Int"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/pgmj.2005.044156","volume":"82","author":"K Ahmed","year":"2006","unstructured":"Ahmed K, Dasgupta P, Khan MS (2006) Cystine calculi: challenging group of stones. Postgrad Med J 82:799\u2013801. \n                    https:\/\/doi.org\/10.1136\/pgmj.2005.044156","journal-title":"Postgrad Med J"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","volume":"20","author":"T Knoll","year":"2005","unstructured":"Knoll T, Zollner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19\u201324. \n                    https:\/\/doi.org\/10.1007\/s00467-004-1663-1","journal-title":"Pediatr Nephrol"},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jcp.27.6.500","volume":"27","author":"AM Asatoor","year":"1974","unstructured":"Asatoor AM, Freedman PS, Gabriel JR, Milne MD, Prosser DI, Roberts JT, Willoughby CP (1974) Amino acid imbalance in cystinuria. J Clin Pathol 27:500\u2013504","journal-title":"J Clin Pathol"},{"key":"1101_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/bmj.4.5738.782","volume":"4","author":"MD Hellier","year":"1970","unstructured":"Hellier MD, Perrett D, Holdsworth CD (1970) Dipeptide absorption in cystinuria. Br Med J 4:782\u2013783","journal-title":"Br Med J"},{"key":"1101_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7257\/1053-816X.2017.37.2.81","volume":"37","author":"B Goldstein","year":"2017","unstructured":"Goldstein B, Goldfarb DS (2017) Early recognition and management of rare kidney stone disorders. Urol Nurs 37:81\u201389, 102","journal-title":"Urol Nurs"},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2215\/cjn.10981114","volume":"10","author":"HL Rhodes","year":"2015","unstructured":"Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, Woodward MN, Smithson SL, Tomson C, Welsh GI, Williams M, Thwaites DT, Sayer JA, Coward RJ (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. CJASN 10:1235\u20131245. \n                    https:\/\/doi.org\/10.2215\/cjn.10981114","journal-title":"CJASN"},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.12894","volume":"116","author":"KA Wong","year":"2015","unstructured":"Wong KA, Mein R, Wass M, Flinter F, Pardy C, Bultitude M, Thomas K (2015) The genetic diversity of cystinuria in a UK population of patients. BJU Int 116:109\u2013116. \n                    https:\/\/doi.org\/10.1111\/bju.12894","journal-title":"BJU Int"},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0022-5347(05)67633-1","volume":"163","author":"F Barbey","year":"2000","unstructured":"Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419\u20131423","journal-title":"J Urol"},{"key":"1101_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-018-1059-5","author":"SL Moore","year":"2018","unstructured":"Moore SL, Somani BK, Cook P (2018) Journey of a cystinuric patient with a long-term follow-up from a medical stone clinic: necessity to be SaFER (stone and fragments entirely removed). Urolithiasis. \n                    https:\/\/doi.org\/10.1007\/s00240-018-1059-5","journal-title":"Urolithiasis"},{"key":"1101_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2215\/cjn.06680714","volume":"10","author":"C Prot-Bertoye","year":"2015","unstructured":"Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Bataille P, Bridoux F, Brignon P, Choquenet C, Cochat P, Combe C, Conort P, Decramer S, Dore B, Dussol B, Essig M, Gaunez N, Joly D, Le Toquin-Bernard S, Mejean A, Meria P, Morin D, N\u2019Guyen HV, Noel C, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M (2015) CKD and Its risk factors among patients with cystinuria. CJASN 10:842\u2013851. \n                    https:\/\/doi.org\/10.2215\/cjn.06680714","journal-title":"CJASN"},{"key":"1101_CR21","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.jpurol.2012.08.006","volume":"9","author":"H Nalcacioglu","year":"2013","unstructured":"Nalcacioglu H, Ozden E, Genc G, Yakupoglu YK, Sarikaya S, Ozkaya O (2013) An uncommon cause of acute kidney injury in young children: cystinuria. J Pediatr Urol 9:e58\u2013e63. \n                    https:\/\/doi.org\/10.1016\/j.jpurol.2012.08.006","journal-title":"J Pediatr Urol"},{"key":"1101_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-5347(05)64824-0","volume":"168","author":"DG Assimos","year":"2002","unstructured":"Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168:27\u201330","journal-title":"J Urol"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2215\/cjn.00320111","volume":"6","author":"DS Goldfarb","year":"2011","unstructured":"Goldfarb DS (2011) Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria. CJASN 6:2093\u20132097. \n                    https:\/\/doi.org\/10.2215\/cjn.00320111","journal-title":"CJASN"},{"key":"1101_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jmg.2004.022244","volume":"42","author":"M Font-Llitjos","year":"2005","unstructured":"Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, Di Perna M, de Sanctis L, Rousaud F, Zelante L, Palacin M, Nunes V (2005) New insights into cystinuria: 40 new mutations, genotype\u2013phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42:58\u201368. \n                    https:\/\/doi.org\/10.1136\/jmg.2004.022244","journal-title":"J Med Genet"},{"key":"1101_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/mgg3.294","volume":"5","author":"P Gaildrat","year":"2017","unstructured":"Gaildrat P, Lebbah S, Tebani A, Sudrie-Arnaud B, Tostivint I, Bollee G, Tubeuf H, Charles T, Bertholet-Thomas A, Goldenberg A, Barbey F, Martins A, Saugier-Veber P, Frebourg T, Knebelmann B, Bekri S (2017) Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants. Mol Genet Genom Med 5:373\u2013389. \n                    https:\/\/doi.org\/10.1002\/mgg3.294","journal-title":"Mol Genet Genom Med"},{"key":"1101_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","volume":"136","author":"PD Stenson","year":"2017","unstructured":"Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665\u2013677. \n                    https:\/\/doi.org\/10.1007\/s00439-017-1779-6","journal-title":"Hum Genet"},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"c159","DOI":"10.1159\/000317196","volume":"116","author":"N Johri","year":"2010","unstructured":"Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:c159\u2013171. \n                    https:\/\/doi.org\/10.1159\/000317196","journal-title":"Nephron Clin Pract"},{"key":"1101_CR28","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.juro.2008.08.057","volume":"180","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Coughlin CRII, Kaplan P (2008) Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children. J Urol 180:2620\u20132623. \n                    https:\/\/doi.org\/10.1016\/j.juro.2008.08.057","journal-title":"J Urol"},{"key":"1101_CR29","first-page":"73","volume":"13","author":"K Wood","year":"2011","unstructured":"Wood K, Keys T, Mufarrij P, Assimos DG (2011) Impact of stone removal on renal function: a review. Rev Urol 13:73\u201389","journal-title":"Rev Urol"},{"key":"1101_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.ajkd.2013.03.041","volume":"62","author":"JR Asplin","year":"2013","unstructured":"Asplin JR, Penniston K, Goldfarb DS (2013) Monosodium urate stones are rare, and urine pH is not low in cystinuria. Am J Kidney Dis 62:179\u2013180. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.041","journal-title":"Am J Kidney Dis"},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.4280","volume":"23","author":"T Zee","year":"2017","unstructured":"Zee T, Bose N, Zee J, Beck JN, Yang S, Parihar J, Yang M, Damodar S, Hall D, O\u2019Leary MN, Ramanathan A, Gerona RR, Killilea DW, Chi T, Tischfield J, Sahota A, Kahn A, Stoller ML, Kapahi P (2017) \u03b1-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria. Nat Med 23:288\u2013290. \n                    https:\/\/doi.org\/10.1038\/nm.4280","journal-title":"Nat Med"},{"key":"1101_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00240-010-0334-x","volume":"39","author":"SB Erickson","year":"2011","unstructured":"Erickson SB, Vrtiska TJ, Canzanello VJ, Lieske JC (2011) Cystone(R) for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res 39:197\u2013203. \n                    https:\/\/doi.org\/10.1007\/s00240-010-0334-x","journal-title":"Urol Res"},{"key":"1101_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00240-013-0621-4","volume":"42","author":"F Modersitzki","year":"2014","unstructured":"Modersitzki F, Pizzi L, Grasso M, Goldfarb DS (2014) Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. Urolithiasis 42:53\u201360. \n                    https:\/\/doi.org\/10.1007\/s00240-013-0621-4","journal-title":"Urolithiasis"},{"issue":"Suppl 3","key":"1101_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bju.13169","volume":"116","author":"JM Parr","year":"2015","unstructured":"Parr JM, Desai D, Winkle D (2015) Natural history and quality of life in patients with cystine urolithiasis: a single centre study. BJU Int 116(Suppl 3):31\u201335. \n                    https:\/\/doi.org\/10.1111\/bju.13169","journal-title":"BJU Int"},{"issue":"S1","key":"1101_CR35","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1089\/end.2016.0564","volume":"31","author":"NM Streeper","year":"2017","unstructured":"Streeper NM, Wertheim ML, Nakada SY, Penniston KL (2017) Cystine stone formers have impaired health-related quality of life compared with noncystine stone formers: a case-referent study piloting the Wisconsin stone quality of life questionnaire among patients with cystine stones. J Endourology 31(S1):S48\u2013Ss53. \n                    https:\/\/doi.org\/10.1089\/end.2016.0564","journal-title":"J Endourology"},{"key":"1101_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.08.2008.0719","author":"B Chabrol","year":"2009","unstructured":"Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G, Creemers JW (2009) Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. BMJ Case Rep. \n                    https:\/\/doi.org\/10.1136\/bcr.08.2008.0719","journal-title":"BMJ Case Rep"},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/156652408785747997","volume":"8","author":"K Martens","year":"2008","unstructured":"Martens K, Jaeken J, Matthijs G, Creemers JW (2008) Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med 8:544\u2013550","journal-title":"Curr Mol Med"},{"key":"1101_CR38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/323624","volume":"69","author":"R Parvari","year":"2001","unstructured":"Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, Hershkovitz E (2001) A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am J Hum Genet 69:869\u2013875. \n                    https:\/\/doi.org\/10.1086\/323624","journal-title":"Am J Hum Genet"},{"key":"1101_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13730-015-0193-y","volume":"5","author":"T de Rojas","year":"2016","unstructured":"de Rojas T, Aparicio C, de Lucas C, Martinez B, Gil-Fournier B, Ramiro-Leon S (2016) Cystinuria in a patient with 19q12q13.1 deletion. CEN Case Rep 5:67\u201369. \n                    https:\/\/doi.org\/10.1007\/s13730-015-0193-y","journal-title":"CEN Case Rep"},{"key":"1101_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3346\/jkms.2010.25.1.172","volume":"25","author":"EH Lee","year":"2010","unstructured":"Lee EH, Kim YH, Hwang JS, Kim SH (2010) Non-type I cystinuria associated with mental retardation and ataxia in a Korean boy with a new missense mutation (G173R) in the SLC7A9 gene. J Korean Med Sci 25:172\u2013175. \n                    https:\/\/doi.org\/10.3346\/jkms.2010.25.1.172","journal-title":"J Korean Med Sci"},{"key":"1101_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/practneurol-2016-001374","volume":"16","author":"R Tohge","year":"2016","unstructured":"Tohge R, Sakamoto S, Takahashi M (2016) A case of cystinuria presenting with cerebellar ataxia and dementia. Pract Neurol 16:296\u2013299. \n                    https:\/\/doi.org\/10.1136\/practneurol-2016-001374","journal-title":"Pract Neurol"},{"key":"1101_CR42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.pediatrneurol.2015.01.018","volume":"52","author":"G Astrea","year":"2015","unstructured":"Astrea G, Munteanu I, Cassandrini D, Lillis S, Trovato R, Pegoraro E, Cioni G, Mercuri E, Muntoni F, Battini R (2015) A diagnostic dilemma in a family with cystinuria type B resolved by muscle magnetic resonance. Pediatr Neurol 52:548\u2013551. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.01.018","journal-title":"Pediatr Neurol"},{"key":"1101_CR43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/brain\/awt202","volume":"137","author":"R Fu","year":"2014","unstructured":"Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, Hegde M, Visser JE, Schretlen DJ, Nyhan WL, Puig JG, O\u2019Neill PJ, Jinnah HA (2014) Genotype\u2013phenotype correlations in neurogenetics: Lesch\u2013Nyhan disease as a model disorder. Brain 137:1282\u20131303. \n                    https:\/\/doi.org\/10.1093\/brain\/awt202","journal-title":"Brain"},{"key":"1101_CR44","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1164\/rccm.201402-0342OC","volume":"189","author":"JA Wambach","year":"2014","unstructured":"Wambach JA, Casey AM, Fishman MP, Wegner DJ, Wert SE, Cole FS, Hamvas A, Nogee LM (2014) Genotype\u2013phenotype correlations for infants and children with ABCA3 deficiency. Am J Resp Crit Care Med 189:1538\u20131543. \n                    https:\/\/doi.org\/10.1164\/rccm.201402-0342OC","journal-title":"Am J Resp Crit Care Med"},{"key":"1101_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3346\/jkms.2017.32.2.310","volume":"32","author":"JH Kim","year":"2017","unstructured":"Kim JH, Park E, Hyun HS, Lee BH, Kim GH, Lee JH, Park YS, Kang HG, Ha IS, Cheong HI (2017) Genotype and phenotype analysis in pediatric patients with cystinuria. J Korean Med Sci 32:310\u2013314. \n                    https:\/\/doi.org\/10.3346\/jkms.2017.32.2.310","journal-title":"J Korean Med Sci"},{"key":"1101_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-018-4269-6","author":"M Mahdavi","year":"2018","unstructured":"Mahdavi M, Koulivand L, Khorrami M, Mirsafaie M, Kheirollahi M (2018) In silico analysis of SLC3A1 and SLC7A9 mutations in Iranian patients with cystinuria. Mol Biol Rep. \n                    https:\/\/doi.org\/10.1007\/s11033-018-4269-6","journal-title":"Mol Biol Rep"},{"issue":"Suppl 5","key":"1101_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12864-017-3913-1","volume":"18","author":"HJ Martell","year":"2017","unstructured":"Martell HJ, Wong KA, Martin JF, Kassam Z, Thomas K, Wass MN (2017) Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine. BMC Genom 18(Suppl 5):550. \n                    https:\/\/doi.org\/10.1186\/s12864-017-3913-1","journal-title":"BMC Genom"},{"key":"1101_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2015.10.039","volume":"69","author":"KA Wong","year":"2016","unstructured":"Wong KA, Wass M, Thomas K (2016) The role of protein modelling in predicting the disease severity of cystinuria. Eur Urol 69:543\u2013544. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.10.039","journal-title":"Eur Urol"},{"key":"1101_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/cge.13079","volume":"92","author":"I Tostivint","year":"2017","unstructured":"Tostivint I, Royer N, Nicolas M, Bourillon A, Czerkiewicz I, Becker PH, Muller F, Benoist JF (2017) Spectrum of mutations in cystinuria patients presenting with prenatal hyperechoic colon. Clin Genet 92:632\u2013638. \n                    https:\/\/doi.org\/10.1111\/cge.13079","journal-title":"Clin Genet"},{"key":"1101_CR50","first-page":"9","volume":"53","author":"T Kato","year":"1977","unstructured":"Kato T (1977) Renal handling of dibasic amino acids and cystine in cystinuria. Clin Sci Mol Med 53:9\u201315","journal-title":"Clin Sci Mol Med"},{"key":"1101_CR51","first-page":"27","volume":"51","author":"AD Stephens","year":"1976","unstructured":"Stephens AD, Perrett D (1976) Cystinuria: a new genetic variant. Clin Sci Mol Med 51:27\u201332","journal-title":"Clin Sci Mol Med"},{"key":"1101_CR52","first-page":"317","volume":"115","author":"J Brodehl","year":"1967","unstructured":"Brodehl J, Gellissen K, Kowalewski S (1967) Isolated cystinuria (without lysin-, ornithin and argininuria) in a family with hypocalcemic tetany. Monatsschrift fur Kinderheilkunde 115:317\u2013320","journal-title":"Monatsschrift fur Kinderheilkunde"},{"key":"1101_CR53","doi-asserted-by":"publisher","first-page":"F995","DOI":"10.1152\/ajprenal.2001.281.6.F995","volume":"281","author":"J Chillaron","year":"2001","unstructured":"Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M (2001) Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol Renal Physiol 281:F995\u2013F1018. \n                    https:\/\/doi.org\/10.1152\/ajprenal.2001.281.6.F995","journal-title":"Am J Physiol Renal Physiol"},{"key":"1101_CR54","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.00071.2002","volume":"283","author":"E Fernandez","year":"2002","unstructured":"Fernandez E, Carrascal M, Rousaud F, Abian J, Zorzano A, Palacin M, Chillaron J (2002) rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for cystine in the kidney. Am J Physiol Renal Physiol 283:F540\u2013F548. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00071.2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"1101_CR55","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/hmg\/ddg228","volume":"12","author":"L Feliubadalo","year":"2003","unstructured":"Feliubadalo L, Arbones ML, Manas S, Chillaron J, Visa J, Rodes M, Rousaud F, Zorzano A, Palacin M, Nunes V (2003) Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis. Hum Mol Genet 12:2097\u20132108. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddg228","journal-title":"Hum Mol Genet"},{"key":"1101_CR56","doi-asserted-by":"publisher","first-page":"F1645","DOI":"10.1152\/ajprenal.00221.2013","volume":"305","author":"A Di Giacopo","year":"2013","unstructured":"Di Giacopo A, Rubio-Aliaga I, Cantone A, Artunc F, Rexhepaj R, Frey-Wagner I, Font-Llitjos M, Gehring N, Stange G, Jaenecke I, Mohebbi N, Closs EI, Palacin M, Nunes V, Daniel H, Lang F, Capasso G, Wagner CA (2013) Differential cystine and dibasic amino acid handling after loss of function of the amino acid transporter b0,+AT (Slc7a9) in mice. Am J Physiol Renal Physiol 305:F1645\u2013F1655. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00221.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"1101_CR57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1073\/pnas.1519959113","volume":"113","author":"S Nagamori","year":"2016","unstructured":"Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K, Nishinaka Y, Bodoy S, Takafuji K, Okuda S, Kurokawa J, Ohgaki R, Nunes V, Palacin M, Kanai Y (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT\/SLC3A1. Proc Natl Acad Sci 113:775\u2013780. \n                    https:\/\/doi.org\/10.1073\/pnas.1519959113","journal-title":"Proc Natl Acad Sci"},{"key":"1101_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11255-009-9597-y","volume":"42","author":"M Ercolani","year":"2010","unstructured":"Ercolani M, Sahota A, Schuler C, Yang M, Evan AP, Reimer D, Barone JG, Tischfield JA, Levin RM (2010) Bladder outlet obstruction in male cystinuria mice. Int Urol Nephrol 42:57\u201363. \n                    https:\/\/doi.org\/10.1007\/s11255-009-9597-y","journal-title":"Int Urol Nephrol"},{"key":"1101_CR59","doi-asserted-by":"publisher","first-page":"e102700","DOI":"10.1371\/journal.pone.0102700","volume":"9","author":"M Livrozet","year":"2014","unstructured":"Livrozet M, Vandermeersch S, Mesnard L, Thioulouse E, Jaubert J, Boffa JJ, Haymann JP, Baud L, Bazin D, Daudon M, Letavernier E (2014) An animal model of type A cystinuria due to spontaneous mutation in 129S2\/SvPasCrl mice. PloS One 9:e102700. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0102700","journal-title":"PloS One"},{"key":"1101_CR60","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/hmg\/ddg189","volume":"12","author":"T Peters","year":"2003","unstructured":"Peters T, Thaete C, Wolf S, Popp A, Sedlmeier R, Grosse J, Nehls MC, Russ A, Schlueter V (2003) A mouse model for cystinuria type I. Hum Mol Genet 12:2109\u20132120. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddg189","journal-title":"Hum Mol Genet"},{"key":"1101_CR61","doi-asserted-by":"publisher","first-page":"e0137277","DOI":"10.1371\/journal.pone.0137277","volume":"10","author":"M Espino","year":"2015","unstructured":"Espino M, Font-Llitjos M, Vilches C, Salido E, Prat E, Lopez de Heredia M, Palacin M, Nunes V (2015) Digenic inheritance in cystinuria mouse model. PloS One 10:e0137277. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0137277","journal-title":"PloS One"},{"key":"1101_CR62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3978\/j.issn.2223-4683.2014.07.04","volume":"3","author":"H Fattah","year":"2014","unstructured":"Fattah H, Hambaroush Y, Goldfarb DS (2014) Cystine nephrolithiasis. Transl Androl Urol 3:228\u2013233. \n                    https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2014.07.04","journal-title":"Transl Androl Urol"},{"key":"1101_CR63","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/ki.2015.254","volume":"88","author":"AL Zisman","year":"2015","unstructured":"Zisman AL, Evan AP, Coe FL, Worcester EM (2015) Do kidney stone formers have a kidney disease? Kidney Int 88:1240\u20131249. \n                    https:\/\/doi.org\/10.1038\/ki.2015.254","journal-title":"Kidney Int"},{"key":"1101_CR64","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1023\/A:1025694230131","volume":"34","author":"A Slavkovic","year":"2002","unstructured":"Slavkovic A, Radovanovic M, Siric Z, Vlajkovic M, Stefanovic V (2002) Extracorporeal shock wave lithotripsy for cystine urolithiasis in children: outcome and complications. Int Urol Nephrol 34:457\u2013461","journal-title":"Int Urol Nephrol"},{"key":"1101_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1023\/B:UROL.0000025632.69605.31","volume":"35","author":"M Gurdal","year":"2003","unstructured":"Gurdal M, Ayyildiz A, Huri E, Kanberoglu H, Karaman MI (2003) A huge bladder cystine stone. Int Urol Nephrol 35:497\u2013499","journal-title":"Int Urol Nephrol"},{"key":"1101_CR66","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0022-5347(17)56125-X","volume":"123","author":"S O\u2019Regan","year":"1980","unstructured":"O\u2019Regan S, Robitaille P, Mongeau JG, Homsy Y (1980) Cystine calcium bladder calculus in a 2-year-old child. J Urol 123:770","journal-title":"J Urol"},{"key":"1101_CR67","doi-asserted-by":"publisher","first-page":"e0159247","DOI":"10.1371\/journal.pone.0159247","volume":"11","author":"K Mizukami","year":"2016","unstructured":"Mizukami K, Raj K, Osborne C, Giger U (2016) Cystinuria associated with different SLC7A9 gene variants in the cat. PloS One 11:e0159247. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0159247","journal-title":"PloS One"},{"key":"1101_CR68","doi-asserted-by":"publisher","first-page":"18249","DOI":"10.1073\/pnas.0607218103","volume":"103","author":"EC Salido","year":"2006","unstructured":"Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J (2006) Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci 103:18249\u201318254. \n                    https:\/\/doi.org\/10.1073\/pnas.0607218103","journal-title":"Proc Natl Acad Sci"},{"key":"1101_CR69","doi-asserted-by":"publisher","first-page":"F732","DOI":"10.1152\/ajprenal.00121.2007","volume":"293","author":"M Font-Llitjos","year":"2007","unstructured":"Font-Llitjos M, Feliubadalo L, Espino M, Cleries R, Manas S, Frey IM, Puertas S, Colell G, Palomo S, Aranda J, Visa J, Palacin M, Nunes V (2007) Slc7a9 knockout mouse is a good cystinuria model for antilithiasic pharmacological studies. Am J Physiol Renal Physiol 293:F732\u2013F740. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00121.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"1101_CR70","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1021\/acs.jmedchem.6b00647","volume":"59","author":"L Hu","year":"2016","unstructured":"Hu L, Yang Y, Aloysius H, Albanyan H, Yang M, Liang JJ, Yu A, Shtukenberg A, Poloni LN, Kholodovych V, Tischfield JA, Goldfarb DS, Ward MD, Sahota A (2016) l-Cystine diamides as l-cystine crystallization inhibitors for cystinuria. J Med Chem 59:7293\u20137298. \n                    https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00647","journal-title":"J Med Chem"},{"key":"1101_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11926-015-0510-7","volume":"17","author":"MH Lee","year":"2015","unstructured":"Lee MH, Sahota A, Ward MD, Goldfarb DS (2015) Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases. Curr Rheumatol Rep 17:33. \n                    https:\/\/doi.org\/10.1007\/s11926-015-0510-7","journal-title":"Curr Rheumatol Rep"},{"key":"1101_CR72","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1021\/acs.cgd.7b00236","volume":"17","author":"LN Poloni","year":"2017","unstructured":"Poloni LN, Zhu Z, Garcia-Vazquez N, Yu AC, Connors DM, Hu L, Sahota A, Ward MD, Shtukenberg AG (2017) Role of molecular recognition in l-cystine crystal growth inhibition. Cryst Growth Design 17:2767\u20132781. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.7b00236","journal-title":"Cryst Growth Design"},{"key":"1101_CR73","doi-asserted-by":"publisher","first-page":"1249.e1249","DOI":"10.1016\/j.urology.2014.07.043","volume":"84","author":"A Sahota","year":"2014","unstructured":"Sahota A, Parihar JS, Capaccione KM, Yang M, Noll K, Gordon D, Reimer D, Yang I, Buckley BT, Polunas M, Reuhl KR, Lewis MR, Ward MD, Goldfarb DS, Tischfield JA (2014) Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model. Urology 84:1249.e1249\u20131249.e1215. \n                    https:\/\/doi.org\/10.1016\/j.urology.2014.07.043","journal-title":"Urology"},{"key":"1101_CR74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4111\/kju.2014.55.8.515","volume":"55","author":"M Shim","year":"2014","unstructured":"Shim M, Park HK (2014) Multimodal treatments of cystine stones: an observational, retrospective single-center analysis of 14 cases. Korean J Urol 55:515\u2013519. \n                    https:\/\/doi.org\/10.4111\/kju.2014.55.8.515","journal-title":"Korean J Urol"},{"key":"1101_CR75","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1021\/ja401309d","volume":"135","author":"T Mandal","year":"2013","unstructured":"Mandal T, Ward MD (2013) Determination of specific binding interactions at L-cystine crystal surfaces with chemical force microscopy. J Am Chem Soc 135:5525\u20135528. \n                    https:\/\/doi.org\/10.1021\/ja401309d","journal-title":"J Am Chem Soc"},{"key":"1101_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1191968","volume":"330","author":"JD Rimer","year":"2010","unstructured":"Rimer JD, An Z, Zhu Z, Lee MH, Goldfarb DS, Wesson JA, Ward MD (2010) Crystal growth inhibitors for the prevention of l-cystine kidney stones through molecular design. Science 330:337\u2013341. \n                    https:\/\/doi.org\/10.1126\/science.1191968","journal-title":"Science"},{"key":"1101_CR77","doi-asserted-by":"publisher","first-page":"17195","DOI":"10.1073\/pnas.1311637110","volume":"110","author":"AG Shtukenberg","year":"2013","unstructured":"Shtukenberg AG, Zhu Z, An Z, Bhandari M, Song P, Kahr B, Ward MD (2013) Illusory spirals and loops in crystal growth. Proc Natl Acad Sci 110:17195\u201317198. \n                    https:\/\/doi.org\/10.1073\/pnas.1311637110","journal-title":"Proc Natl Acad Sci"},{"key":"1101_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.03.024","author":"Y Yang","year":"2018","unstructured":"Yang Y, Albanyan H, Lee S, Aloysius H, Liang JJ, Kholodovych V, Sahota A, Hu L (2018) Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria. Bioorg Med Chem Lett. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.024","journal-title":"Bioorg Med Chem Lett"},{"key":"1101_CR79","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00467-011-2092-6","volume":"27","author":"DJ Claes","year":"2012","unstructured":"Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27:2031\u20132038. \n                    https:\/\/doi.org\/10.1007\/s00467-011-2092-6","journal-title":"Pediatr Nephrol"},{"key":"1101_CR80","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1172\/JCI26662","volume":"115","author":"FL Coe","year":"2005","unstructured":"Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598\u20132608","journal-title":"J Clin Invest"},{"key":"1101_CR81","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00726-013-1631-9","volume":"46","author":"A Masotti","year":"2014","unstructured":"Masotti A, Laurenzi C, Boenzi S, Pastore A, Taranta A, Bellomo F, Muraca M, Dionisi-Vici C, Bertucci P, Dello Strologo L, Emma F (2014) Gender-related effects on urine l-cystine metastability. Amino Acids 46:415\u2013427. \n                    https:\/\/doi.org\/10.1007\/s00726-013-1631-9","journal-title":"Amino Acids"},{"key":"1101_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1155\/2013\/292953","volume":"292953","author":"KP Aggarwal","year":"2013","unstructured":"Aggarwal KP, Narula S, Kakkar M, Tandon C (2013) Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int 292953:21. \n                    https:\/\/doi.org\/10.1155\/2013\/292953","journal-title":"Biomed Res Int"},{"key":"1101_CR83","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5527\/wjn.v3.i4.256","volume":"3","author":"JM Baumann","year":"2014","unstructured":"Baumann JM, Affolter B (2014) From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis. World J Nephrol 3:256\u2013267","journal-title":"World J Nephrol"},{"key":"1101_CR84","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2017","unstructured":"Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius H-G (2017) Kidney stones. Nat Rev Dis Primers 2:16008. \n                    https:\/\/doi.org\/10.1038\/nrdp.2016.8","journal-title":"Nat Rev Dis Primers"},{"key":"1101_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00240-016-0948-8","volume":"45","author":"JD Rimer","year":"2017","unstructured":"Rimer JD, Kolbach-Mandel AM, Ward MD, Wesson JA (2017) The role of macromolecules in the formation of kidney stones. Urolithiasis 45:57\u201374. \n                    https:\/\/doi.org\/10.1007\/s00240-016-0948-8","journal-title":"Urolithiasis"},{"key":"1101_CR86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12018-011-9104-8","volume":"9","author":"VN Ratkalkar","year":"2011","unstructured":"Ratkalkar VN, Kleinman JG (2011) Mechanisms of Stone Formation. Clin Rev Bone Miner Metabol 9:187\u2013197. \n                    https:\/\/doi.org\/10.1007\/s12018-011-9104-8","journal-title":"Clin Rev Bone Miner Metabol"},{"key":"1101_CR87","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00240-004-0455-1","volume":"33","author":"JA Wesson","year":"2005","unstructured":"Wesson JA, Ganne V, Beshensky AM, Kleinman JG (2005) Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 33:206\u2013212. \n                    https:\/\/doi.org\/10.1007\/s00240-004-0455-1","journal-title":"Urol Res"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-018-1101-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-018-1101-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-018-1101-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:08:07Z","timestamp":1589623687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-018-1101-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s00240-018-1101-7","relation":{},"ISSN":["2194-7228","2194-7236"],"issn-type":[{"value":"2194-7228","type":"print"},{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"19 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance ethical standards"}},{"value":"Dr. Goldfarb has received consulting fees from Retrophin. The other authors declare that they have no relevant financial interests. The work described in this manuscript on cystine diamides has been licensed by Rutgers University to PharmaKrysto. Rutgers University is the assignee of Patent Number US 9,248,453 B2 entitled \u201cCystine diamide analogs for the prevention of cystine stone formation in cystinuria\u201d and New York University is the assignee of Patent Number US 8,450,089 B2 entitled \u201cCompounds as L-cystine crystallization inhibitors and uses thereof\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee of Rutgers University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}